Attenuation correction improves the detection of viable myocardium by thallium-201 cardiac tomography in patients with previous myocardial infarction and left ventricular dysfunction

European Journal of Nuclear Medicine

Volumn 26, Issue 5, 1999, Pages 459-466

  Gallowitsch, Hans Jürgen ^a,b   Unterweger, Oliver ^a   Mikosch, Peter ^a   Kresnik, Ewald ^a   Sykora, Josef ^a   Grimm, Georg ^a   Lind, Peter ^a  

^a GENERAL HOSPITAL KLAGENFURT   (Austria)

^b Department of Cardiology ^*  (Austria)

Author keywords

Attenuation correction; Myocardial infarction; Single photon emission tomography; Thallium 201 reinjection; Viability

Indexed keywords

THALLIUM 201;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL PROTOCOL; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE BLOOD FLOW; HEART SCINTISCANNING; HUMAN; IMAGE QUALITY; MAJOR CLINICAL STUDY; MALE; RADIATION ATTENUATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0032944134     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050411     Document Type: Article

References (12)

1. 1. Ohtani H, Tamaki N, Yonekura Y, et al. Value of thallium-201 reinjection after delayed SPET imaging for predicting reversible ischemia after coronary artery bypass grafting. Am J Cardiol 1990; 66: 394-399.
2. 2. Dilsizian V, Rocco TP, Freedman NMT, Leon MB, Bonow RO. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 1990; 323: 141-146.
3. 3. Bonow RO, Dilsizian V, Cuocolo A, Bacharach SL. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with F-18 fluorodeoxyglucose. Circulation 1991; 83: 26-37.
4. 4. Tamaki N, Ohtani H, Yamashita K, et al. Metabolic activity in the areas of new fill-in after thallium-201 reinjection: comparison with positron emission tomography using fluorine-18-deoxyglucose. J Nucl Med 1991; 32: 673-678.
5. 5. Tan P, Bailey D, Meikle S et al. A scanning line source for simultaneous emission and transmission measurements in SPET. J Nucl Med 1993; 34: 1752-1760.
6. 6. TRANSACT Operation Manual. 1996. Elscint Ltd., Technical Writing Department, Haifa, Israel.
7. 7. Beller GA. Assessment of myocardial perfusion and metabolism for assessment of myocardial viability. Q J Nucl Med 1996; 40: 55-67.
8. 201T1 in patients with chronic coronary artery disease and left ventricular dysfunction. Circulation 1992; 86: 1125-1137.
9. 9. Rossetti C, Landoni C, Lucignani G, Huang G, et al. Assessment of myocardial perfusion and viability with technetium-99 m methoxyisobutylisonitrile and thallium-201 rest redistribution in chronic coronary artery disease. Eur J Nucl Med 1995; 22: 1306-1312.
10. 10. Gallowitsch HJ, Sykora J, Mikosch P, Kresnik E, Unterweger O, Grimm G, Lind P. Attenuation-corrected thallium-201 single-photon emission tomography using a gadolinium-153 moving line source: clinical value and the impact of attenuation correction on the extent and severity of perfusion abnormalities. Eur J Nucl Med 1998; 25: 220-228.
11. 11. Ficaro EP, Fessler JA, Ackermann RJ; Rogers WL, Corbett JR, Schwaiger M. Simultaneous transmission-emission thallium-201 cardiac SPET: effect of attenuation correction on myocardial tracer distribution. J Nucl Med 1995; 36: 921-931.
12. 12. Heller EN, DeMan P, Liu YH, Dione DP, Zubal G, Wackers FJT, Sinusas AJ. Extracardiac activity complicates quantitative cardiac SPET imaging using a simultaneous transmission-emission approach. J Nucl Med 1997; 38: 1882-1890.